×
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
NASDAQ:MOTS

Motus GI (MOTS) Stock Forecast, Price & News

$0.28
0.00 (0.00%)
(As of 05/27/2022 04:00 PM ET)
Add
Compare
Today's Range
$0.27
$0.28
50-Day Range
$0.24
$0.40
52-Week Range
$0.23
$1.22
Volume
1.43 million shs
Average Volume
1.24 million shs
Market Capitalization
$15.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.4
30 days | 90 days | 365 days | Advanced Chart
Receive MOTS News and Ratings via Email

Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter.

Motus GI logo

About Motus GI

Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MOTS
Employees
30
Year Founded
N/A

Sales & Book Value

Annual Sales
$390 thousand
Book Value
$0.16 per share

Profitability

Net Income
$-19.03 million
Net Margins
-5,331.94%
Pretax Margin
-5,331.94%

Debt

Price-To-Earnings

Miscellaneous

Free Float
51,103,000
Market Cap
$15.09 million
Optionable
Not Optionable

Company Calendar

Last Earnings
3/29/2022
Today
5/27/2022
Next Earnings (Estimated)
8/11/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.73 out of 5 stars

Medical Sector

880th out of 1,424 stocks

Surgical & Medical Instruments Industry

92nd out of 137 stocks

Analyst Opinion: 3.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -













Motus GI (NASDAQ:MOTS) Frequently Asked Questions

Is Motus GI a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Motus GI stock.
View analyst ratings for Motus GI
or view top-rated stocks.

Are investors shorting Motus GI?

Motus GI saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 2,510,000 shares, a decrease of 16.6% from the April 30th total of 3,010,000 shares. Based on an average daily volume of 591,800 shares, the short-interest ratio is presently 4.2 days.
View Motus GI's Short Interest
.

When is Motus GI's next earnings date?

Motus GI is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our earnings forecast for Motus GI
.

How were Motus GI's earnings last quarter?

Motus GI Holdings, Inc. (NASDAQ:MOTS) announced its earnings results on Tuesday, March, 29th. The company reported ($0.10) earnings per share for the quarter, hitting the consensus estimate of ($0.10). The firm had revenue of $0.10 million for the quarter, compared to analysts' expectations of $0.14 million. Motus GI had a negative trailing twelve-month return on equity of 152.78% and a negative net margin of 5,331.94%. During the same period last year, the business earned ($0.12) EPS.
View Motus GI's earnings history
.

What price target have analysts set for MOTS?

2 Wall Street analysts have issued 1 year price objectives for Motus GI's shares. Their forecasts range from $1.40 to $1.50. On average, they expect Motus GI's stock price to reach $1.47 in the next twelve months. This suggests a possible upside of 433.3% from the stock's current price.
View analysts' price targets for Motus GI
or view top-rated stocks among Wall Street analysts.

Who are Motus GI's key executives?
Motus GI's management team includes the following people:
What other stocks do shareholders of Motus GI own?
When did Motus GI IPO?

(MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

What is Motus GI's stock symbol?

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

Who are Motus GI's major shareholders?

Motus GI's stock is owned by a variety of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (0.13%). Company insiders that own Motus GI stock include Andrew Lawrence Taylor, Darren Sherman, David P Hochman, Larry N Feinberg, Mark Pomeranz, Perceptive Advisors Llc and Timothy P Moran.
View institutional ownership trends for Motus GI
.

Which major investors are buying Motus GI stock?

MOTS stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. Company insiders that have bought Motus GI stock in the last two years include Andrew Lawrence Taylor, Darren Sherman, David P Hochman, Mark Pomeranz, and Timothy P Moran.
View insider buying and selling activity for Motus GI
or or view top insider-buying stocks.

How do I buy shares of Motus GI?

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Motus GI's stock price today?

One share of MOTS stock can currently be purchased for approximately $0.28.

How much money does Motus GI make?

Motus GI has a market capitalization of $15.09 million and generates $390 thousand in revenue each year. The company earns $-19.03 million in net income (profit) each year or ($0.39) on an earnings per share basis.

How many employees does Motus GI have?

Motus GI employs 30 workers across the globe.

What is Motus GI's official website?

The official website for Motus GI is www.motusgi.com.

How can I contact Motus GI?

Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301. The company can be reached via phone at (954) 541-8000, via email at [email protected], or via fax at 954-541-8265.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.